Scientific Advisory Board
Prof David Nutt DM FRCP FRCPSYCH FSB FMEDSCI
Chair of Scientific Advisory Board
Neuropsychopharmacology chair at the Imperial College London, President of the The European Brain Council, and former President of the European College of Neuropsychopharmacology
Prof Alan Schatzberg MD
Member of Scientific Advisory Board
Director at the Stanford Mood Disorders Center and Professor of Psychiatry at the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Diego Pizzagalli PhD
Member of Scientific Advisory Board
Diego Pizzagalli is an experimental psychologist and neuroscientist. He is a Professor of Psychiatry at the Harvard Medical School. At the McLean Hospital, he is the Director of the McLean Imaging Center, the Director of the Center for Depression, Anxiety and Stress Research, the Director of Research at the Division of Depression & Anxiety Disorders, as well as the Director of the Laboratory for Affective and Translational Neuroscience.
Gül Dölen, M.D., Ph.D
Member of the Scientific Advisory Board
Assistant Professor of Neuroscience, Brain Science Institute, Wendy Klag Center for Autism & Developmental Disabilities, Kavli Neuroscience Discovery Institute, the Johns Hopkins University, School of Medicine
John Rush MD
Member of Scientific Advisory Board
Dr Rush is a professor of psychiatry with positions including Professor Emeritus at Duke-National University of Singapore (Duke-NUS) and CEO of Curbstone Consultant LLC.
Kirk Rutter
Special Advisor, Patient Experience
Kirk is a technologist for a London University. He became a volunteer patient on the 2015 Imperial College clinical study of psilocybin therapy for treatment-resistant depression (TRD).
Prof Paul Summergrad MD
Member of Scientific Advisory Board
Prof Paul Summergrad MD is the Dr Frances S Arkin professor and chairman of the Department of Psychiatry and professor of medicine at Tufts University School of Medicine and psychiatrist-in-chief at Tufts Medical Center. He is the past president of the American Psychiatric Association.
Robin L Carhart-Harris PhD
Member of Scientific Advisory Board
Dr Robin Carhart-Harris is Director of the Centre for Psychedelic Research at Imperial College London.
Tom Insel MD
Member of Scientific Advisory Board
Thomas Insel MD is a psychiatrist and neuroscientist who served as Director of the US National Institute of Mental Health (NIMH), Professor of Psychiatry at Emory University and founding director of the Centre for Behavioural Neuroscience in Atlanta.
Zachary Mainen PhD
Member of Scientific Advisory Board
Zachary Mainen is a neuroscientist whose research focuses on the brain mechanisms of decision-making. He founded the Champalimaud Neuroscience Programme and Champalimaud Research, where he held the position of Director and Co-Director until 2019.